Asia Spotlight: BeiGene CEO John Oyler On Building A Biotech In China
The CEO of one of China’s hottest start-ups sits down to talk about his strategy, the state of innovation in China and how to access funding from the Chinese government.
You may also be interested in...
China's State Intellectual Property Office (SIPO) is drafting a new regulation on "service innovation" to encourage companies and researchers in the country to raise their investment in, and the conduct of, innovation. However, the move may also have an impact on the soaring drug discovery industry in China as it will mean higher payments to inventors with knock-on effects on local drug discovery and CROs.